Glen Eagle Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$794 Buy
+2
New +$569 ﹤0.01% 1005
2025
Q4
Sell
-200
Closed -$52K 1088
2025
Q3
$52K Buy
+200
New +$52.6K 0.01% 444
2024
Q4
Sell
-7
Closed -$2.22K 1132
2024
Q3
$2.22K Hold
7
﹤0.01% 892
2024
Q2
$2.62K Sell
7
-193
-97% -$65.2K ﹤0.01% 862
2024
Q1
$69.3K Hold
200
0.01% 357
2023
Q4
$91.6K Hold
200
0.02% 306
2023
Q3
$97.3K Hold
200
0.02% 290
2023
Q2
$89.4K Buy
+200
New +$101K 0.02% 302
2022
Q3
Sell
-200
Closed -$93.6K 1113
2022
Q2
$93.6K Buy
+200
New +$89K 0.03% 286
2018
Q2
Sell
-7
Closed -$1.88K 698
2018
Q1
$1.88K Sell
7
-3
-30% -$812 ﹤0.01% 593
2017
Q4
$2.48K Hold
10
﹤0.01% 560
2017
Q3
$2.44K Buy
10
+6
+150% +$1.47K ﹤0.01% 573
2017
Q2
$962 Buy
+4
New +$906 ﹤0.01% 567

Other funds holding HUM

Glen Eagle Advisors's HUM Position: Q2 2026 in Review

Glen Eagle Advisors opened a new position in Humana (HUM) in Q2 2026: 2 shares worth $794. The stake represents ﹤0.01% of the portfolio and ranks #1005 among its holdings. This is a return to the name: Glen Eagle Advisors previously reported a position in HUM as recently as Q3 2025.

Glen Eagle Advisors first reported a position in HUM in Q2 2017 and has held it in 13 quarters since. The position peaked at $97.3K in Q3 2023. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Glen Eagle Advisors held 2 shares of Humana worth $794 as of Q2 2026.
  • Humana was a new Glen Eagle Advisors position in Q2 2026.
  • Humana made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #1005 holding.
  • Glen Eagle Advisors first reported a position in Humana in Q2 2017 and has held it in 13 quarters since.
  • Glen Eagle Advisors's Humana position peaked at $97.3K in Q3 2023.
  • 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.